ABSTRACT NUMBER: ESOC2026YS267 NMR LIPOPROTEIN PARTICLE PROFILING IN CEREBROVASCULARDISEASE: DIFFERENTIAL EFFECTS OF STATINS, EZETIMIBE, AND PCSK9 INHIBITORS
Adi Abdulaziz R Aldubaiyan, Muna Alnamlah, Mohammed Alkhudhair, Mohammed Alqurishi, Haifa Alsuwaine, Ashfaq Shuaib, Naser Alotaibi · 2026
Read ABSTRACT NUMBER: ESOC2026YS267 NMR LIPOPROTEIN PARTICLE PROFILING IN CEREBROVASCULARDISEASE: DIFFERENTIAL EFFECTS OF STATINS, EZETIMIBE, AND PCSK9 INHIBITORS by Adi Abdulaziz R Aldubaiyan, Muna Alnamlah, Mohammed Alkhudhair, Mohammed Alqurishi, Haifa Alsuwaine, Ashfaq Shuaib, Naser Alotaibi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13145543.txt.
Description
Adi Abdulaziz R Aldubaiyan and six co-authors describe an ongoing study of how cholesterol-lowering drugs reshape lipoprotein particles in people with cerebrovascular disease. This 2026 conference abstract notes that standard lipid tests measure cholesterol content, not the number, size, and makeup of the particles carrying it. A scanning method based on nuclear magnetic resonance can profile those particles in detail, but drug effects on them are little mapped.
The prospective study enrolls adults with stroke-related disease or white matter disease from neurovascular clinics and hospital wards. Fasting particle profiles are taken at the start and again at six months, with an extra scan whenever treatment changes sooner. Drugs in play are statins, ezetimibe, and PCSK9 inhibitors, alone or combined. The abstract reports that the study began a month before writing, with enrollment and data collection under way. Results will come from adjusted comparisons between treatment groups.
Catalog record
| CREATOR | Adi Abdulaziz R Aldubaiyan, Muna Alnamlah, Mohammed Alkhudhair, Mohammed Alqurishi, Haifa Alsuwaine, Ashfaq Shuaib, Naser Alotaibi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |